论文部分内容阅读
有望防治哮喘的新药ＩＬ－４Ｒ旧金山消息：旨在吸收白细胞介素－４（ＩＬ－４）分子的一种遗传工程药物的初期试验结果显示，该药物耐受性良好，ＩＬ－４是化学链中导致哮喘发作的一种关键物质。丹佛国立免疫学和呼吸医学中心的变态反应和免疫学家ＬａｒｙＢｏｒｉｓｈ说...
IL-4R, a New Drug That Prevents Alleviation of Asthma SAN FRANCISCO (MarketWatch) - Initial tests of a genetically engineered drug designed to uptake interleukin-4 (IL-4) molecules show that the drug is well tolerated and that IL-4 is a chemical In the lead asthma attack a key material. Lary Borish, an allergist and immunologist at the Denver State Immunology and Respiratory Medicine Center, said ...